The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market From 2026 To 2030?
The market size for temperature-stable messenger ribonucleic acid (mrna) vials has experienced rapid expansion in recent years. It is projected to increase from $2.01 billion in 2025 to $2.28 billion in 2026, at a compound annual growth rate (CAGR) of 13.6%. The historical growth of this market can be ascribed to the expansion of mrna vaccine research, augmented investment in lipid nanoparticle technologies, a rise in global immunization programs, constraints related to cold-chain logistics, and the initial implementation of stabilized mrna delivery systems.
The market for temperature-stable messenger ribonucleic acid (mRNA) vials is projected to experience swift expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $3.77 billion, demonstrating a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth over the projected timeframe include the escalating demand for advanced mRNA therapeutics, a heightened emphasis on ensuring worldwide vaccine availability, the broadening of decentralized healthcare services, increasing capital allocation towards temperature-stable biologics, and a surge in regulatory endorsements for products utilizing mRNA technology. Key developments foreseen during this period encompass the accelerated creation of thermostable mRNA formulations, a greater uptake of lyophilized mRNA vials, an expanding need for storage options that do not rely on a cold chain, the enlargement of worldwide mRNA distribution initiatives, and a stronger emphasis on the robustness and stability of packaging.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29229&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?
The rising involvement in global vaccination is projected to drive the expansion of the temperature-stable messenger ribonucleic acid (mRNA) vial market moving forward. A vaccine is a compound designed to stimulate the body’s immune system, aiding in developing defenses against specific illnesses. The surge in worldwide vaccine engagement is propelled by international collaboration, where coordinated efforts among nations guarantee broader access and equitable distribution of vaccines. Temperature-stable mRNA vials support global vaccination by enabling easier storage, transportation, and distribution across diverse regions without requiring complex cold chain infrastructure, thereby ensuring wider availability and sustained immunization coverage globally. For example, in October 2025, Gavi, a US-based international organization providing vaccines to children in developing countries, reported that DTP3 vaccine coverage in Gavi-supported lower-income countries increased to 82%, up from 80% in 2023, nearing pre-pandemic levels. Therefore, the growing participation in global vaccination is fueling the growth of the temperature-stable messenger ribonucleic acid (mRNA) vial market.
Which Segments Are Included In The Analysis Of The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?
The temperature-stable messenger ribonucleic acid (mrna) vial market covered in this report is segmented –
1) By Product Type: Lipid Nanoparticle Formulations, Polymer-Based Formulations, Lyophilized Messenger Ribonucleic Acid (mRNA) Vials, Other Product Types
2) By Distribution Channel: Direct Sales, Distributors, Online Sales, Other Distribution Channels
3) By Application: Vaccines, Therapeutics, Research, Other Applications
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Lipid Nanoparticle Formulations: Cationic Lipid Nanoparticles, Ionizable Lipid Nanoparticles, Neutral Lipid Nanoparticles
2) By Polymer-Based Formulations: Polyethylene Glycol-Based Formulations, Polymeric Micelles, Dendrimer-Based Formulations
3) By Lyophilized Messenger Ribonucleic Acid Vials: Single-Dose Vials, Multi-Dose Vials
4) By Others Product Types: Peptide-Based Formulations, Protein-Based Formulations, Hybrid Formulations
Which Trends Are Impacting The Growth Of The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?
Leading firms in the temperature-stable messenger ribonucleic acid (mRNA) vial market are concentrating on creating novel strategies, including technology transfer models, to boost manufacturing efficiency, broaden worldwide production capabilities, and increase vaccine access in low- and middle-income nations. These technology transfer models describe methods for imparting knowledge, expertise, and production techniques between organizations to facilitate localized manufacturing and broader distribution. As an example, in January 2024, SCHOTT Pharma, a pharmaceutical packaging firm based in Germany, introduced its EVERIC freeze vials. The EVERIC freeze vials can endure temperatures down to -80°C, rendering them appropriate for vaccines and medications like mRNA and gene therapy treatments applied in cases of infectious diseases, cancer, and central nervous system conditions. Their design, optimized for strength, minimizes the potential for breakage, thereby avoiding the waste of vital medications and expensive operational interruptions.
Which Key Industry Participants Are Active In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?
Major companies operating in the temperature-stable messenger ribonucleic acid (mrna) vial market are Arcturus Therapeutics Holdings Inc., CureVac AG, Sanofi S.A., Lonza Group AG, Gerresheimer AG, Stevanato Group, Schott AG, CSafe Global, Gennova Biopharmaceuticals Ltd., TTP Group, Peli BioThermal LLC, SiO2 Materials Science, Shijiazhuang Xinfuda Medical Packaging, Vaxess Technologies, Ethris, Lyophilization Techniques, 20Med Therapeutics BV, EnsiliTech, HDT Bio Corp., Emervax.
Read the full temperature-stable messenger ribonucleic acid (mrna) vial market report here:
https://www.thebusinessresearchcompany.com/report/temperature-stable messenger-ribonucleic-acid-mrna vial-global-market-report
What Are The Leading Geographic Regions In The Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market?
North America was the largest region in the temperature-stable messenger ribonucleic acid (mRNA) vial market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the temperature-stable messenger ribonucleic acid (mrna) vial market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29229&type=smp
Browse Through More Reports Similar to the Global Temperature-Stable Messenger Ribonucleic Acid (mRNA) Vial Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Ribonucleic Acid Rna Sequencing Market Report 2026
Nucleic Acid Labeling Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model